-
Je něco špatně v tomto záznamu ?
Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
J. Beljantseva, P. Kudrin, S. Jimmy, M. Ehn, R. Pohl, V. Varik, Y. Tozawa, V. Shingler, T. Tenson, D. Rejman, V. Hauryliuk,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
PubMed
28157202
DOI
10.1038/srep41839
Knihovny.cz E-zdroje
- MeSH
- Escherichia coli genetika metabolismus MeSH
- guanosintetrafosfát metabolismus farmakologie MeSH
- ligasy antagonisté a inhibitory genetika metabolismus MeSH
- mutageneze * MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC50 in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001324
- 003
- CZ-PrNML
- 005
- 20190108130322.0
- 007
- ta
- 008
- 190107s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/srep41839 $2 doi
- 035 __
- $a (PubMed)28157202
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Beljantseva, Jelena $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
- 245 10
- $a Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor / $c J. Beljantseva, P. Kudrin, S. Jimmy, M. Ehn, R. Pohl, V. Varik, Y. Tozawa, V. Shingler, T. Tenson, D. Rejman, V. Hauryliuk,
- 520 9_
- $a The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC50 in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work.
- 650 _2
- $a Escherichia coli $x genetika $x metabolismus $7 D004926
- 650 _2
- $a guanosintetrafosfát $x metabolismus $x farmakologie $7 D006159
- 650 _2
- $a ligasy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D008025
- 650 12
- $a mutageneze $7 D016296
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kudrin, Pavel $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
- 700 1_
- $a Jimmy, Steffi $u Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
- 700 1_
- $a Ehn, Marcel $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Pohl, Radek $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Varik, Vallo $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia. Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
- 700 1_
- $a Tozawa, Yuzuru $u Graduate School of Science and Engineering, Saitama University, 255 Shimo-Okubo, Sakura-ku, Saitama, Saitama 338-8570, Japan.
- 700 1_
- $a Shingler, Victoria $u Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden.
- 700 1_
- $a Tenson, Tanel $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia.
- 700 1_
- $a Rejman, Dominik $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., Flemingovo nám. 2, 166 10 Prague 6, Czech Republic.
- 700 1_
- $a Hauryliuk, Vasili $u University of Tartu, Institute of Technology, Nooruse 1, 50411 Tartu, Estonia. Department of Molecular Biology, Umeå University, Building 6K, 6L University Hospital Area, SE-901 87 Umeå, Sweden. Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Building 6K and 6L, University Hospital Area, SE-901 87 Umeå, Sweden.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 41839
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28157202 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190108130522 $b ABA008
- 999 __
- $a ok $b bmc $g 1365208 $s 1039447
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c - $d 41839 $e 20170203 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20190107